Recent years, genome-wide association studies (GWAS) and fine-mapping analyses had identified several SNP variants within HNF1B gene associated with hyper promoter DNA methylation, reduced HNF1B expression, and increased risk of prostate cancer [15–21], indicating a tumor suppressive role of HNF1B in prostate cancer development. This evidence concerns the gene HNF1B and neoplasm.